Table 2 Effects of COVID-19 on Patients According to Patient Advocacy Organizations in Latin America, 2020, N = 81
Yes | No | Do not Know | Missing | |
|---|---|---|---|---|
n (%) | n (%) | n (%) | n | |
In general, have the majority of your patients reported experiencing delays in receiving treatment/care? | ||||
Patient Reported Delays | ||||
Treatment and care delays | 67 (82.72) | 13 (16.05) | NA | 1 |
Treatment and care delays > 30 Days | 42 (51.85) | 38 (46.91) | NA | 1 |
Treatment and care delays ≤ 30 Days | 25 (30.86) | 55 (67.90) | NA | 1 |
What are some of the biggest impacts the COVID-19 pandemic has had on your patients? Select “yes” if the issue has been impacted, “no” if the issue has not been impacted, or “I do not know.” | ||||
Personal Factors | ||||
Overall Impact | NA (90.95) | NA (4.12) | NA (3.29) | NA |
Patient fear of going to the hospital for treatment | 75 (92.59) | 4 (4.94) | 2 (2.47) | 0 |
Increased feelings of isolation and depression | 74 (91.36) | 4 (4.94) | 1 (1.23) | 2 |
Financial uncertainty | 72 (88.89) | 2 (2.47) | 5 (6.17) | 2 |
Structural Factors | ||||
Overall Impact | NA (63.95) | NA (19.01) | NA (15.56) | NA |
Consultations and/or surgeries postponed | 74 (91.36) | 4 (4.94) | 2 (2.47) | 1 |
Delayed screening and late diagnosis | 65 (80.25) | 10 (12.35) | 5 (6.17) | 1 |
Limited or no access to telemedicine | 47 (58.02) | 20 (24.69) | 13 (16.05) | 1 |
Treatment not available due to limited staffing | 38 (46.91) | 29 (35.80) | 12 (14.81) | 2 |
Decreased participation in clinical trials | 35 (43.21) | 14 (17.28) | 31 (38.27) | 1 |
Clinical Factors | ||||
Overall Impact | NA (60.08) | NA (30.86) | NA (7.41) | NA |
Lapse in treatment | 57 (70.37) | 19 (23.46) | 4 (4.94) | 1 |
Medication not available due to medication stock out | 46 (56.79) | 28 (34.57) | 6 (7.41) | 1 |
Change in treatment protocols | 43 (53.09) | 28 (34.57) | 8 (9.88) | 2 |